- Home
- UCL vs CALC Comparison
UCL vs CALC Comparison
Compare UCL & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UCL
- CALC
- Stock Information
- Founded
- UCL 2014
- CALC 2011
- Country
- UCL Hong Kong
- CALC United States
- Employees
- UCL N/A
- CALC N/A
- Industry
- UCL Telecommunications Equipment
- CALC Biotechnology: Pharmaceutical Preparations
- Sector
- UCL Consumer Discretionary
- CALC Health Care
- Exchange
- UCL Nasdaq
- CALC Nasdaq
- Market Cap
- UCL 48.7M
- CALC 40.3M
- IPO Year
- UCL 2020
- CALC N/A
- Fundamental
- Price
- UCL $2.13
- CALC $2.76
- Analyst Decision
- UCL
- CALC Strong Buy
- Analyst Count
- UCL 0
- CALC 5
- Target Price
- UCL N/A
- CALC $18.20
- AVG Volume (30 Days)
- UCL 374.6K
- CALC 69.1K
- Earning Date
- UCL 11-26-2024
- CALC 11-13-2024
- Dividend Yield
- UCL N/A
- CALC N/A
- EPS Growth
- UCL 169.91
- CALC N/A
- EPS
- UCL 0.11
- CALC N/A
- Revenue
- UCL $87,405,000.00
- CALC N/A
- Revenue This Year
- UCL $11.23
- CALC N/A
- Revenue Next Year
- UCL $27.52
- CALC N/A
- P/E Ratio
- UCL $18.65
- CALC N/A
- Revenue Growth
- UCL 4.73
- CALC N/A
- 52 Week Low
- UCL $0.97
- CALC $2.05
- 52 Week High
- UCL $3.30
- CALC $8.38
- Technical
- Relative Strength Index (RSI)
- UCL 62.21
- CALC 34.02
- Support Level
- UCL $1.41
- CALC $2.67
- Resistance Level
- UCL $3.30
- CALC $2.90
- Average True Range (ATR)
- UCL 0.39
- CALC 0.26
- MACD
- UCL 0.11
- CALC 0.00
- Stochastic Oscillator
- UCL 45.33
- CALC 50.35
About UCL uCloudlink Group Inc.
Ucloudlink Group Inc provides mobile data connectivity and portable WiFi services. The business operates under uCloudlink 1.0, which focuses on cross-border travelers that need mobile data connectivity services across different countries. Under uCloudlink 2.0, provides mobile data connectivity services to local users across different MNOs in a single country. It generates revenue from the provision of data connectivity services, and the sales of terminals and sales of data related products.
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.